Aspirin on par with dalteparin in preventing VTE after hip replacement

06/4/2013 | Medscape (free registration)

Aspirin performed comparably to dalteparin in preventing venous thromboembolism following total hip arthroplasty, according to a 778-patient study in the Annals of Internal Medicine. There were no major bleeding events in the group given aspirin, while there was one case in the dalteparin group. Clinically significant nonmajor bleeding and minor bleeding were reported more often in the dalteparin group than the aspirin group.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Executive Vice President-MyHealth First Network
Greenville Health System
Greenville, SC
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Director, Health Plan Operations
Group Health Cooperative
Seattle, WA